UNLOCKD Reports 76% Month-Over-Month Revenue Growth at Ancient Extracts Following Acquisition
BitFrontier Capital Holdings, doing business as UNLOCKD, reported preliminary May revenue of $22,344 for its newly acquired subsidiary Ancient Extracts, a 76% increase from April, signaling early commercial momentum in the wellness sector.
BitFrontier Capital Holdings, Inc. (OTCID: BFCH), operating as UNLOCKD Inc., announced strong preliminary revenue growth from its recently acquired subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA, underscoring the company's pivot toward a revenue-generating wellness platform. The update, released on June 11, 2026, reveals that May 2026 revenue reached approximately $22,344, a 76% increase from April's preliminary revenue of $12,670.
The company noted that operations under UNLOCKD ownership began in mid-May following the acquisition's close, meaning the reported May figure reflects only a partial month of operations. Additionally, on June 2, 2026, Ancient Extracts received a purchase order valued at approximately $58,823 in retail product value, with a wholesale order total of about $29,411.
CEO John P. Gorst highlighted the early commercial traction, stating that the combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces the company's belief in the acquisition. Ancient Extracts offers a portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha, shilajit, and other wellness goods under the brand philosophy of "Ancient Remedies for Modern Life." The company believes the brand is well-positioned to benefit from growing consumer interest in functional mushrooms, adaptogens, and botanical wellness products.
Chairman and Chief Science Officer Dr. Jordan P. Balencic emphasized the subsidiary's attractive characteristics, including a differentiated product portfolio, loyal customer base, and capital-efficient operating model. He noted that while integration is still early, initial operating results and commercial traction reinforce conviction in the opportunity. UNLOCKD's objective is to grow revenue, expand distribution, and strengthen its portfolio of wellness assets through disciplined execution.
Separately, the company's UNLOCKD Technologies division has begun preliminary planning for future consumer health technology opportunities, including early-stage evaluation of point-of-care testing concepts. Management has initiated discussions with developers, suppliers, and potential strategic partners, though these initiatives remain conceptual. The company expects any future technology development to follow a milestone-driven approach and anticipates seeking dedicated financing for such projects.
The news matters because it demonstrates UNLOCKD's ability to generate revenue growth post-acquisition, validating its strategy of building a scalable wellness platform. The purchase order and month-over-month revenue increase indicate market demand for Ancient Extracts' products, while the technology division's early planning suggests potential expansion into health tech. For investors, the preliminary financials offer a glimpse into the company's operational trajectory, though they remain unaudited and subject to adjustment.
For more information, visit UNLOCKD Inc..